513 material Form 8-K filings that 427 companies we cover made with the SEC in November 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
BioLife Solutions agreed to sell all shares of its wholly owned subsidiary Custom Biogenic Systems (CBS) to Standex International for an aggregate price of about $6.1 million, subject to adjustment, and the sale closed on November 14, 2024. The filing says the company also paid $2.0 million in accelerated share compensation to former employees and repaid about $1.5 million of CBS debt, and its pro forma figures show a $840,000 loss on the sale.
Buyer is Standex International Corporation; sale price is about $6.1 million, subject to adjustment, with closing on November 14, 2024
Company incurred $2.0 million in compensation expense from accelerating unvested shares for former employees who stayed with CBS
Company was required to repay about $1.5 million of CBS indebtedness; pro forma loss on sale of CBS is $840,000 as of September 30, 2024
Company will provide transition services to CBS and is bound by two-year non-compete and non-solicitation covenants
N-able said on November 20, 2024 that it completed its acquisition of Adlumin, Inc., a cybersecurity company that provides extended detection and response and managed detection and response services. The company paid $100 million in cash and 1,570,762 shares of its common stock at closing, with additional deferred cash and up to $30 million in earn-out payments tied to performance targets. The filing also gave updated fourth-quarter and full-year 2024 revenue and adjusted EBITDA outlooks.
Closed November 20, 2024: about $100 million in cash, subject to customary adjustments, plus 1,570,762 shares of common stock
Deferred cash of $120 million, paid as $52.5 million and $67.5 million on the first and second anniversaries of closing
Up to $30 million in earn-out payments in 2025 and 2026 based on performance metrics
Full-year 2024 total revenue outlook of $463.0 million to $464.5 million, representing 10% year-over-year growth; fourth-quarter revenue outlook of $113.3 million to $114.8 million
Acadia Pharmaceuticals said Executive Vice President, Chief Operating Officer and Head of Commercial Brendan Teehan was involuntarily terminated without Cause, effective immediately. Mr. Teehan will stay on as a non-executive employee through December 31, 2024 to help transfer his duties to a successor, and CEO Catherine Owen Adams will assume his responsibilities until one is appointed.
Brendan Teehan's executive role ended effective immediately, per an agreement dated November 18, 2024
Teehan remains a non-executive employee until December 31, 2024 to assist with the transition
CEO Catherine Owen Adams will assume his responsibilities until a successor is appointed
The filing does not name a successor or state the reason for the termination
Assurant named Kevin Warren, former chief marketing and customer experience officer at UPS, to its Board of Directors and its Compensation and Talent Committee, effective January 15, 2025, subject to customary regulatory approval. Two directors are also leaving the board: Lawrence V. Jackson will retire at the 2025 annual meeting, and Paget L. Alves will resign effective January 15, 2025 to become CEO of Sorenson.
Kevin Warren joins the board and Compensation and Talent Committee effective January 15, 2025, subject to customary regulatory approval.
Warren served as chief marketing and customer experience officer at UPS from 2018 to 2024 and spent 34 years at Xerox Corporation.
Lawrence V. Jackson retires effective at the 2025 annual meeting of stockholders.
Paget L. Alves resigns from the board effective January 15, 2025 to become CEO of Sorenson.
At its 2024 Annual Meeting on November 20, 2024, Performance Food Group stockholders elected 12 directors to one-year terms, ratified Deloitte & Touche LLP as auditor for fiscal 2025, and approved the compensation of named executive officers in a non-binding vote. They also approved the 2024 Omnibus Incentive Plan, which governs the company's equity incentive program, so shareholders' approval of the plan is now in place. The filing does not report financial results.
Twelve directors elected, including George L. Holm and Warren M. Thompson; the most votes against any director was 2,290,778 (Jeffrey M. Overly)
2024 Omnibus Incentive Plan approved with 140,803,363 votes for and 1,753,164 against
Deloitte & Touche LLP ratified as independent auditor for fiscal 2025 with 145,299,856 votes for and 2,403,379 against
Advisory vote on named executive officer compensation approved with 141,673,998 votes for and 843,122 against
On November 18, 2024, Merchants Bancorp agreed with a group of underwriters to sell 9.2 million depositary shares, each representing a 1/40th interest in its 7.625% Series E non-cumulative perpetual preferred stock, with a $25 liquidation value per depositary share. The company expects to use the net proceeds to redeem its Series B preferred stock and for general corporate purposes, including supporting balance sheet growth at Merchants Bank, with closing expected November 25, 2024.
9,200,000 depositary shares offered, each with a $25 liquidation value and a 1/40th interest in a Series E preferred share
Dividends at 7.625% per annum, payable quarterly when declared by the board, starting January 1, 2025
Offering expected to close on or about November 25, 2024; proceeds to redeem Series B preferred stock and for general corporate purposes
Horace Mann Educators disclosed that Kimberly Johnson, its Senior Vice President, Controller and Principal Accounting Officer, plans to retire effective January 3, 2025. Chief Financial Officer Ryan Greenier will take on the Principal Accounting Officer role when she retires, so the change is administrative and does not alter the company's financial results.
Kimberly Johnson, SVP, Controller and Principal Accounting Officer, plans to retire effective January 3, 2025
Johnson joined the company in 2002 as Assistant Controller and became Vice President and Controller in April 2017
Ryan Greenier, Executive Vice President and CFO, will become Principal Accounting Officer upon her retirement
Wingstop and its subsidiaries signed a purchase agreement on November 19, 2024, under which a special purpose subsidiary will issue and sell $500 million of Series 2024-1 5.858% Fixed Rate Senior Secured Notes, Class A-2, in a private securitization. The closing is expected on December 3, 2024, subject to closing conditions, and the notes carry an anticipated repayment date in December 2031 with a legal final maturity in December 2054.
$500 million of Series 2024-1 5.858% Fixed Rate Senior Secured Notes, Class A-2, to be issued by Wingstop Funding LLC
Anticipated repayment date in December 2031; legal final maturity in December 2054
If not repaid or refinanced by the anticipated repayment date, additional interest accrues at the greater of 5.00% per annum and a Treasury-based formula plus 5.00% and 1.60%
Closing expected Tuesday, December 3, 2024; Morgan Stanley & Co. LLC and Barclays Capital Inc. are the initial purchasers
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.